The author summarizes the role of all-trans retinoic acidin normal hematopoiesis and in cute amyeloid leukemia (AML), focusing on its impact on AML stem cells.
[Cell Cycle]
6807162 {6807162:W9HGVETS} apa 50 1 154037 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-14cee23c69a09e90d8e69fc3a6d0af6b%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22W9HGVETS%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nguyen%20et%20al.%22%2C%22parsedDate%22%3A%222020-09-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENguyen%2C%20C.%20H.%2C%20Grandits%2C%20A.%20M.%2C%20Purton%2C%20L.%20E.%2C%20Sill%2C%20H.%2C%20%26amp%3B%20Wieser%2C%20R.%20%282020%29.%20All-trans%20retinoic%20acid%20in%20non-promyelocytic%20acute%20myeloid%20leukemia%3A%20driver%20lesion%20dependent%20effects%20on%20leukemic%20stem%20cells.%20%3Ci%3ECell%20Cycle%3C%5C%2Fi%3E%2C%20%3Ci%3E0%3C%5C%2Fi%3E%280%29%2C%201%26%23x2013%3B16.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F15384101.2020.1810402%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F15384101.2020.1810402%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DW9HGVETS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22All-trans%20retinoic%20acid%20in%20non-promyelocytic%20acute%20myeloid%20leukemia%3A%20driver%20lesion%20dependent%20effects%20on%20leukemic%20stem%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi%20H.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20M.%22%2C%22lastName%22%3A%22Grandits%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louise%20E.%22%2C%22lastName%22%3A%22Purton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinz%22%2C%22lastName%22%3A%22Sill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rotraud%22%2C%22lastName%22%3A%22Wieser%22%7D%5D%2C%22abstractNote%22%3A%22Acute%20myeloid%20leukemia%20%28AML%29%20is%20an%20aggressive%2C%20often%20fatal%20hematopoietic%20malignancy.%20All-trans%20retinoic%20acid%20%28atRA%29%2C%20one%20of%20the%20first%20molecularly%20targeted%20drugs%20in%20oncology%2C%20has%20greatly%20improved%20the%20outcome%20of%20a%20subtype%20of%20AML%2C%20acute%20promyelocytic%20leukemia%20%28APL%29.%20In%20contrast%2C%20atRA%20has%20so%20far%20provided%20little%20therapeutic%20benefit%20in%20the%20much%20larger%20group%20of%20patients%20with%20non-APL%20AML.%20Attempts%20to%20identify%20genetically%20or%20molecularly%20defined%20subgroups%20of%20patients%20that%20may%20respond%20to%20atRA%20have%20not%20yielded%20consistent%20results.%20Since%20AML%20is%20a%20stem%20cell-driven%20disease%2C%20understanding%20the%20effectiveness%20of%20atRA%20may%20require%20an%20appreciation%20of%20its%20impact%20on%20AML%20stem%20cells.%20Recent%20studies%20reported%20that%20atRA%20decreased%20stemness%20of%20AML%20with%20an%20FLT3-ITD%20mutation%2C%20yet%20increased%20it%20in%20AML1-ETO%20driven%20or%20EVI1-overexpressing%20AML.%20This%20review%20summarizes%20the%20role%20of%20atRA%20in%20normal%20hematopoiesis%20and%20in%20AML%2C%20focusing%20on%20its%20impact%20on%20AML%20stem%20cells.%22%2C%22date%22%3A%22September%208%2C%202020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1080%5C%2F15384101.2020.1810402%22%2C%22ISSN%22%3A%221538-4101%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F15384101.2020.1810402%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-09-11T20%3A48%3A55Z%22%7D%7D%5D%7D
Nguyen, C. H., Grandits, A. M., Purton, L. E., Sill, H., & Wieser, R. (2020). All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells. Cell Cycle, 0(0), 1–16. https://doi.org/10.1080/15384101.2020.1810402 Cite